Kymera Therapeutics KYMR Increase Decrease In Operating Lease Right Of Use Assets
Increase Decrease In Operating Lease Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's increase decrease in operating lease right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's increase decrease in operating lease right of use assets?
- Kymera Therapeutics (KYMR) reported increase decrease in operating lease right of use assets of -$615K in Q1 2026.
- How has Kymera Therapeutics's increase decrease in operating lease right of use assets changed year-over-year?
- Kymera Therapeutics's increase decrease in operating lease right of use assets increased by 8.6% year-over-year, from -$673K to -$615K.
- What is the long-term trend for Kymera Therapeutics's increase decrease in operating lease right of use assets?
- Over 4 years (2021 to 2025), Kymera Therapeutics's increase decrease in operating lease right of use assets has grown at a 58.8% compound annual growth rate (CAGR), from -$419K to -$2.67M.
- What does increase decrease in operating lease right of use assets mean?
- Captures the net change in the carrying value of right-of-use assets recognized under operating lease agreements. This adjustment accounts for the amortization of the asset over the lease term and reflects changes in the company's leased infrastructure footprint.